Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Cheng-Chuan Su

Cheng-Chuan Su

Tzu Chi University, Taiwan

Title: Human Herpesvirus type 8 in patients with chronic hepatitis

Biography

Biography: Cheng-Chuan Su

Abstract

A high seroprevalence of human herpesvirus type (HHV-8) in mild cirrhotics is significantly associated with hepatitis activity. Cirrhosis is almost derived from chronic hepatitis. We aimed to evaluate the prevalence of HHV-8 infection in patients with chronic hepatitis. Blood samples collected from 129 patients with chronic hepatitis and 129 age- and sexmatched healthy controls were analyzed for monocyte and platelet counts, hepatitis B surface antigen (HBsAg), anti hepatitis C virus (anti-HCV), HHV-8 antibody and DNA, and alanine aminotransferase (ALT). Mean monocyte and platelet counts were significantly higher and lower in patients than in healthy controls (P = 0.02 and < 0.0001, respectively). Seropositive rate for HHV-8 antibodies was significantly greater in patients (32.6%) than in controls (20.9%, P = 0.04), particularly in patients with HCV infection, or higher plasma ALT levels, or both (P = 0.004, 0.01, and 0.0009, respectively). Antibody titers for HHV-8 in patients also exceeded those in controls (P = 0.02). The mean age of HHV-8 seropositive patients (60.3 years) was significantly older than that of seronegative (52.3 years) (P = 0.0007). Patients aged 55 or older had higher seropositive rate and titers for HHV-8 antibodies than those younger (P = 0.005 and 0.007, respectively). A significantly high HHV-8 seroprevalence is already present in patients with chronic hepatitis before the development of cirrhosis, particularly in patients with HCV infection and/or higher plasma ALT levels. Advancing age seems to play an important role in HHV-8 seroprevalence in a patient with chronic hepatitis.